Cytomx Therapeutics Inc (CTMX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cytomx Therapeutics Inc   (NASDAQ: CTMX)


Cytomx Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cytomx Therapeutics Inc's ROI in the second quarter of 2026?
Cytomx Therapeutics Inc recorded a cumulative net loss of $-80 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -35.84%.

Within the Healthcare sector 397 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3234 to 3545.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 272.47 % 473.42 % 265.96 % 175.18 % 35 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 341 325 105 117 136
Return On Investment (TTM) -35.84 % -34.62 % -17.1 % 33.34 % 80.43 %
CTMX's Overall Ranking # 3545 # 3234 # 2980 # 156 # 52
Seq. Investment Change TTM 30.08 % 68.18 % 20.88 % 40.84 % 100.25 %
Seq. Net Income Change TTM - - - -41.61 % 15.34 %
Net Income (TTM) in Millions -80 -59 -17 28 48

CTMX Company Profile >> Back to CTMX Roi Comparisons >> See Annual CTMX Return On Investment



Return On Investment CTMX's Ranking
Within: No.
Industry # 156
Sector # 398
Overall # 3545

Return On Investment Statistics
High Average Low
139.64 %
-15.83 %
-72.61 %
(Mar 31 2025)   (Dec 31 2015)







Financial Statements
Cytomx Therapeutics Inc's II. Quarter Investments $ 341 Millions CTMX's Balance sheet
Cytomx Therapeutics Inc's II. Quarter Income $ -21 Millions Quarterly CTMX's Income Statement
CTMX's Income by Division See CTMX's Income by Division


CTMX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 105 35 46 108 262
Y / Y Investment Growth 201.92 % -24.23 % -57.63 % -58.6 % 1.48 %
Net Income in Millions -17 32 -1 -99 -116
Y / Y Net Income Growth - - - - -
Annual Return On Investment -16.55 % 91.68 % -1.24 % -91.72 % -44.3 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CTMX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CTMX's Competitors
Subscribers only: Roi for Cytomx Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CTMX's Customers

Other Ratios
CTMX's Roa CTMX's Inventory Turnover Ratio CTMX's Growth Rates CTMX's Dividend Statistics
CTMX's Profitability Ratios CTMX's Asset Turnover Ratio CTMX's Dividend Growth
CTMX's Roe CTMX's Valuation Ratios CTMX's Financial Strength Ratios CTMX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:24:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.